Meeting
2020 Genitourinary Cancers Symposium
PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).
Authors
Tian Zhang
Duke Cancer Institute, Durham, NC
Tian Zhang , Karla V. Ballman , Atish Dipankar Choudhury , Ronald C. Chen , Colleen Watt , Yujia Wen , Tyler Zemla , Hamid Emamekhoo , Ulka N. Vaishampayan , Michael J. Morris , Daniel J. George , Toni K. Choueiri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT03793166
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr TPS760)
Abstract #
TPS760
Poster Bd #
K16
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).
First Author: Tian Zhang
Poster
2020 ASCO Virtual Scientific Program
PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).
First Author: Tian Zhang
Poster
2019 ASCO Annual Meeting
PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).
First Author: Tian Zhang
Poster
2023 ASCO Genitourinary Cancers Symposium
Impact of number of treatment lines following first-line (1L) immuno-oncology (IO) combination on overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC).
First Author: Audreylie Lemelin